News & Perspective

May 24, 2019

May 24, 2019

ASP Scan (Weekly) for May 24, 2019

WHA and antimicrobial resistance
Urgent sepsis antibiotics
Resistant Pseudomonas from Mexico
Antibiotic prescribing nudge
Unnecessary testing, treatment for kids' pneumonia
Fewer antibiotics for implant infections
Artificial intelligence for AMR

May 20, 2019

May 20, 2019

News Scan for May 20, 2019

MERS in Saudi Arabia
Fewer antibiotics for implant infections
Artificial intelligence for AMR

Nov 16, 2018

Nov 16, 2018

ASP Scan (Weekly) for Nov 16, 2018

Improper prescribing in the ER
Hospital stewardship in China
Antibiotic use in Poland
Swiss AMR-related illness, deaths
Antibiotic use in Scotland
Drug-resistant malaria in India
Spread of resistant bacteria in hospitals
Health departments against antimicrobial resistance
Public concern over antibiotic resistance
Nov 16, 2018

Stewardship / Resistance Scan for Nov 16, 2018

Improper prescribing in the ER
Hospital stewardship in China
Antibiotic use in Poland
Swiss AMR-related illness, deaths

Nov 17, 2017

Nov 17, 2017

ASP Scan (Weekly) for Nov 17, 2017

Primary care stewardship
No-touch superbug disinfection
Surgical antimicrobial prescribing
Ceftriaxone-resistant gonorrhea
E coli ST131
Single-room ICU design
ECDC CRE guidance
European research funding
Optimal MDR-TB treatment
Real-time resistance tracker
Salmonella in calves
Drug-resistant malaria controversy
US AMR progress
Antimicrobial use in Northern Ireland
Resistance in space

May 18, 2011

May 18, 2011

Experts: Regulatory issues are main reason for keeping smallpox virus

(CIDRAP News) – When the World Health Assembly (WHA) considers the fate of the remaining stocks of smallpox virus this week, the debate is likely to be framed in part by a report from a group of independent experts that says the only strong reason for keeping the virus is to satisfy strict regulatory requirements for new vaccines and antivirals.

Jul 07, 2010

Jul 07, 2010

Non-vaccine aid for needy nations' pandemic response falls short

(CIDRAP News) – While donor countries and organizations have responded well to the need for pandemic flu vaccine for developing countries, the level of giving for other pandemic response efforts in needy countries so far has fallen short, the World Health Organization (WHO) said in a recent report.

Apr 26, 2007

Apr 26, 2007

Roche cuts Tamiflu production as demand cools

(CIDRAP News) – The Swiss pharmaceutical company Roche announced today it is scaling back production of oseltamivir (Tamiflu) because of waning demand, and simultaneously questioned whether countries stockpiling the drug are buying enough to protect their citizens in the event of an influenza pandemic.

Pages

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3MAccelerate DiagnosticsGilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»